为癌细胞提供一个安全的避风港:通过DYRK1B控制瘤加上侧膜瘤
Miriam Ems1, Anna Brichkina2, Matthias Lauth3
1Department of Gastroenterology, Endocrinology and Metabolism, Center for Tumor and Immune Biology, Philipps University Marburg, Marburg, Germany.
Oncogene
|January 25, 2025
概括
双特异性氨酸酸化调节激酶1B (DYRK1B) 通过保护瘤细胞和瘤微环境 (TME) 来驱动癌症耐药性. 向DYRK1B提供了一种新的治疗策略,用于克服固体恶性瘤中治疗阻力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 耐药性是癌症治疗的一个主要挑战,影响所有治疗方式.
- 抵抗源于癌细胞和瘤微环境 (TME) 的适应过程.
- 向瘤和脑膜两部分对于未来的癌症疗法至关重要.
研究的目的:
- 审查双特异性氨酸-酸化调节激酶1B (DYRK1B) 作为瘤媒介的作用.
- 突出DYRK1B在克服癌症药物耐药性的潜力.
- 探索DYRK1B对癌细胞和TME的影响.
主要方法:
- 对DYRK1B在固体恶性瘤中的功能进行文献综述.
- 对DYRK1B细胞自主和TME相关的瘤活动的分析.
- 检查DYRK1B在免疫检查点调节和巨细胞功能中的作用.
主要成果:
- 在卵巢和胰腺癌等高增殖性恶性瘤中,DYRK1B过度表达.
- DYRK1B促进癌细胞存活,化学抵抗和疾病复发.
- DYRK1B通过上调免疫检查点和下调抗瘤巨细胞来调节TME.
结论:
- DYRK1B 作为一个关键的调解者,为癌细胞创造了一个保护.
- DYRK1B既影响了癌细胞内在的过程,也影响了外在的TME功能.
- DYRK1B 是一个有吸引力的治疗点,可以提高癌症治疗的疗效.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


